Nvidia shares fell more than 1.6% on Monday, though they remained above the firm’s 50-day moving average. The decline reflects a combination of year-end profit-taking—after a 35% gain in 2025—and investor questions about the company’s capital allocation in emerging technologies. Trading volume on the session was approximately 20% above the 30-day average, indicating that the pullback drew notable participation from institutional accounts. Technical analysts have highlighted that a sustained hold above the 50-day line would support a bullish case heading into January.

Sources indicate Nvidia is set to acquire most of AI chipmaker Groq’s assets for roughly $20 billion in cash, in a move designed to strengthen its inference technology portfolio. The transaction is expected to include a non-exclusive licensing agreement for Groq’s inference IP, allowing Nvidia to integrate the startup’s low-latency architecture into its data-center GPUs. If consummated, the deal would represent Nvidia’s largest acquisition since its $6.9 billion purchase of Mellanox in 2019 and could add an estimated 10% incremental compute throughput across key AI workloads.

With the Consumer Electronics Show kicking off in Las Vegas on January 5, Nvidia CEO Jensen Huang will deliver the opening keynote that many analysts view as a bellwether for corporate AI budgets in 2026. Wedbush Securities forecasts that global enterprise AI spending could grow by more than 40% next year, with Nvidia platforms accounting for two-thirds of projected data-center GPU deployments. Investor attention will focus on any new partnerships, pricing models or roadmap milestones that Huang announces, as these could influence capital expenditure plans for hyperscalers throughout the year.

Regulatory filings show that company insiders sold over $1.7 billion worth of Nvidia stock during 2025, reducing insider ownership to approximately 4.17%. CEO Jensen Huang led the activity with multiple Rule 10b5-1 plan sales totaling more than 650,000 shares, including a July transaction of roughly 205,000 shares and a September sale of 225,000 shares. Other directors and senior officers disposed of similar volumes in consecutive months. While pre-scheduled plans limit the informational value of individual trades, the aggregate scale of divestment has prompted governance analysts to flag potential shifts in insider confidence as the stock approaches record highs.